Eterna Therapeutics
ERNA
#11171
Rank
โ‚ฌ2.09 M
Marketcap
1,24ย โ‚ฌ
Share price
-16.56%
Change (1 day)
2.91%
Change (1 year)

Eterna Therapeutics (ERNA) - P/B ratio

P/B ratio as of November 2026 : 0.7775

According to Eterna Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eterna Therapeutics - P/B ratio (from 2021 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-313.79-50.37%
2024-12-317.6475.7%
2023-12-314.35218.94%
2022-12-311.36-83.98%
2021-12-318.51
2020-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Sanofi
SNY
1.42 82.15%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
2.14 174.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-19.4-2,591.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
2.65 240.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
3.03 289.29%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
5.99 670.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
5.42 596.92%๐Ÿ‡บ๐Ÿ‡ธ USA